Contributors
Recent Posts
- Health Care Industry Employers Time to Redouble Efforts to Avoid Claims of Disability Discrimination (Part 1)
- Resident Discharge From a Michigan HFA: A Reminder
- Office of Civil Rights Fines Dental Practice for Disclosure of PHI on YELP
- HHS Proposes Anti-Kickback Statute and Stark Law Revisions Protecting Value-Based Arrangements and Care Coordination
- CMS Issues New Reporting Requirements for Providers and Suppliers
- Eleventh Circuit Rejects Expert Challenge to Clinical Judgment Decision in Hospice False Claims Act Litigation
- DHHS Issues Proposed Rule Amending 42 CFR Part 2
- CMS Repeals Prohibition on Pre-Binding Arbitration for Long-Term Care Providers
- The New Hazardous Waste Pharmaceuticals Rule: A Few Practical Steps to Prepare
- Overpayments and Statistical Sampling and Extrapolation in OIG Claims Audits
Related Practices
- Adoption & Assisted Reproductive Technology
- Ambulatory Care Providers
- Bankruptcy, Insolvency & Creditors' Rights
- Bioethics & End-of-Life Care
- Biotechnology and Life Science
- Cannabis Law
- Government Investigations and Corporate Compliance
- Health Care
- Health Care Administrative Law & Regulatory Appeals
- HIPAA—Health Information Privacy & Security
- Hospitals and Health Care Systems
- Long-Term & Post-Acute Care Providers
- Nonprofits & Tax-Exempt Organizations
- Pharmacies, DEA & Robinson-Patman/340B Drug Programs
- Physicians, Dentists and Non-Physician Practitioners
Related Industries
Michigan Department of Licensing and Regulatory Affairs Finalizes “Opioid Start Talking” Form for Mandatory Use with Opioid Prescriptions Starting June 1, 2018
Public Act 246 of 2017 includes two separate requirements for prescribers to obtain a patient’s signature certifying the receipt of information about opioids prior to prescribing a controlled substance containing an opioid for the patient. The first is a requirement that a prescriber use a “Start Talking” informed consent-type form when prescribing an opioid for a minor, with some exceptions. The second is a requirement that a patient sign a form approved by the Michigan Department of Licensing and Regulatory Affairs (“LARA”) certifying the receipt of certain opioid information from a licensed health professional prior to having an opioid prescribed for the patient (minor or adult) for other than for inpatient use. Both requirements go into effect June 1, 2018.
LARA worked with stakeholders to develop a single form that will satisfy both the Start Talking form and opioid information form requirements of PA 246 of 2017. Last week, LARA posted its approved “Opioid Start Talking” form (MDHHS-5730 (4-18a)) on its website under “Information for Prescribers.”The form is a single page document that is intended to be retained in the patient’s medical record.
Starting June 1, 2018, prescribers must begin using the Opioid Start Talking form with all patients receiving controlled substance prescriptions containing an opioid, except in the following situations:
1. The opioid is being prescribed for inpatient use for an adult.
2. The opioid is being prescribed for inpatient use for a minor in one of the following situations:
- Minor’s treatment is associated with or incident to a medical emergency.
- Minor’s treatment is associated with or incident to inpatient surgery.
- In the prescriber’s professional medical judgement, using the form and/or process would be detrimental to the minor’s health or safety.
- The minor’s treatment is rendered in a hospice or in the oncology department of a licensed hospital.
- The prescriber is issuing the prescription when the minor is being discharged from a hospice or from the oncology department of a licensed hospital.
- Consent of the minor’s parent/guardian is not legally required for the minor to obtain treatment.
LARA has announced plans to post FAQs regarding the 2017 Michigan opioid legislation on its website this spring, presumably including questions regarding the Opioid Start Talking Form. Look here for a summary of the 2017 Michigan controlled substance and opioid legislation.
To sign up for Dykema’s Health Care Blog e-mail updates, please click here.